-
1
-
-
60849115270
-
IDH1 and IDH2 mutations in gliomas
-
Yan H, Parsons DW, Jin G, McLendon R, Rasheed BA, Yuan W, Kos I, Batinic-Haberle I, Jones S, Riggins GJ, Friedman H, Friedman A, Reardon D, Herndon J, Kinzler KW, Velculescu VE, et al. IDH1 and IDH2 mutations in gliomas. The New England journal of medicine. 2009; 360(8):765-773.
-
(2009)
The New England journal of medicine.
, vol.360
, Issue.8
, pp. 765-773
-
-
Yan, H.1
Parsons, D.W.2
Jin, G.3
McLendon, R.4
Rasheed, B.A.5
Yuan, W.6
Kos, I.7
Batinic-Haberle, I.8
Jones, S.9
Riggins, G.J.10
Friedman, H.11
Friedman, A.12
Reardon, D.13
Herndon, J.14
Kinzler, K.W.15
Velculescu, V.E.16
-
2
-
-
52949127312
-
An integrated genomic analysis of human glioblastoma multiforme
-
Parsons DW, Jones S, Zhang X, Lin JC, Leary RJ, Angenendt P, Mankoo P, Carter H, Siu IM, Gallia GL, Olivi A, McLendon R, Rasheed BA, Keir S, Nikolskaya T, Nikolsky Y, et al. An integrated genomic analysis of human glioblastoma multiforme. Science. 2008; 321(5897):1807-1812.
-
(2008)
Science.
, vol.321
, Issue.5897
, pp. 1807-1812
-
-
Parsons, D.W.1
Jones, S.2
Zhang, X.3
Lin, J.C.4
Leary, R.J.5
Angenendt, P.6
Mankoo, P.7
Carter, H.8
Siu, I.M.9
Gallia, G.L.10
Olivi, A.11
McLendon, R.12
Rasheed, B.A.13
Keir, S.14
Nikolskaya, T.15
Nikolsky, Y.16
-
3
-
-
72049125350
-
Cancer-associated IDH1 mutations produce 2-hydroxyglutarate
-
Dang L, White DW, Gross S, Bennett BD, Bittinger MA, Driggers EM, Fantin VR, Jang HG, Jin S, Keenan MC, Marks KM, Prins RM, Ward PS, Yen KE, Liau LM, Rabinowitz JD, et al. Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature. 2009; 462(7274):739-744.
-
(2009)
Nature.
, vol.462
, Issue.7274
, pp. 739-744
-
-
Dang, L.1
White, D.W.2
Gross, S.3
Bennett, B.D.4
Bittinger, M.A.5
Driggers, E.M.6
Fantin, V.R.7
Jang, H.G.8
Jin, S.9
Keenan, M.C.10
Marks, K.M.11
Prins, R.M.12
Ward, P.S.13
Yen, K.E.14
Liau, L.M.15
Rabinowitz, J.D.16
-
4
-
-
77649305610
-
The common feature of leukemiaassociated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate
-
Ward PS, Patel J, Wise DR, Abdel-Wahab O, Bennett BD, Coller HA, Cross JR, Fantin VR, Hedvat CV, Perl AE, Rabinowitz JD, Carroll M, Su SM, Sharp KA, Levine RL and Thompson CB. The common feature of leukemiaassociated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate. Cancer cell. 2010; 17(3):225-234.
-
(2010)
Cancer cell.
, vol.17
, Issue.3
, pp. 225-234
-
-
Ward, P.S.1
Patel, J.2
Wise, D.R.3
Abdel-Wahab, O.4
Bennett, B.D.5
Coller, H.A.6
Cross, J.R.7
Fantin, V.R.8
Hedvat, C.V.9
Perl, A.E.10
Rabinowitz, J.D.11
Carroll, M.12
Su, S.M.13
Sharp, K.A.14
Levine, R.L.15
Thompson, C.B.16
-
5
-
-
78651463452
-
Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of alphaketoglutarate-dependent dioxygenases
-
Xu W, Yang H, Liu Y, Yang Y, Wang P, Kim SH, Ito S, Yang C, Wang P, Xiao MT, Liu LX, Jiang WQ, Liu J, Zhang JY, Wang B, Frye S, et al. Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of alphaketoglutarate-dependent dioxygenases. Cancer cell. 2011; 19(1):17-30.
-
(2011)
Cancer cell.
, vol.19
, Issue.1
, pp. 17-30
-
-
Xu, W.1
Yang, H.2
Liu, Y.3
Yang, Y.4
Wang, P.5
Kim, S.H.6
Ito, S.7
Yang, C.8
Wang, P.9
Xiao, M.T.10
Liu, L.X.11
Jiang, W.Q.12
Liu, J.13
Zhang, J.Y.14
Wang, B.15
Frye, S.16
-
6
-
-
84858796263
-
IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype
-
Turcan S, Rohle D, Goenka A, Walsh LA, Fang F, Yilmaz E, Campos C, Fabius AW, Lu C, Ward PS, Thompson CB, Kaufman A, Guryanova O, Levine R, Heguy A, Viale A, et al. IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype. Nature. 2012; 483(7390):479-483.
-
(2012)
Nature.
, vol.483
, Issue.7390
, pp. 479-483
-
-
Turcan, S.1
Rohle, D.2
Goenka, A.3
Walsh, L.A.4
Fang, F.5
Yilmaz, E.6
Campos, C.7
Fabius, A.W.8
Lu, C.9
Ward, P.S.10
Thompson, C.B.11
Kaufman, A.12
Guryanova, O.13
Levine, R.14
Heguy, A.15
Viale, A.16
-
7
-
-
84858796262
-
IDH mutation impairs histone demethylation and results in a block to cell differentiation
-
Lu C, Ward PS, Kapoor GS, Rohle D, Turcan S, Abdel-Wahab O, Edwards CR, Khanin R, Figueroa ME, Melnick A, Wellen KE, O'Rourke DM, Berger SL, Chan TA, Levine RL, Mellinghoff IK, et al. IDH mutation impairs histone demethylation and results in a block to cell differentiation. Nature. 2012; 483(7390):474-478.
-
(2012)
Nature.
, vol.483
, Issue.7390
, pp. 474-478
-
-
Lu, C.1
Ward, P.S.2
Kapoor, G.S.3
Rohle, D.4
Turcan, S.5
Abdel-Wahab, O.6
Edwards, C.R.7
Khanin, R.8
Figueroa, M.E.9
Melnick, A.10
Wellen, K.E.11
O'Rourke, D.M.12
Berger, S.L.13
Chan, T.A.14
Levine, R.L.15
Mellinghoff, I.K.16
-
8
-
-
84870538996
-
A heterozygous IDH1R132H/WT mutation induces genome-wide alterations in DNA methylation
-
Duncan CG, Barwick BG, Jin G, Rago C, Kapoor-Vazirani P, Powell DR, Chi JT, Bigner DD, Vertino PM and Yan H. A heterozygous IDH1R132H/WT mutation induces genome-wide alterations in DNA methylation. Genome research. 2012; 22(12):2339-2355.
-
(2012)
Genome research.
, vol.22
, Issue.12
, pp. 2339-2355
-
-
Duncan, C.G.1
Barwick, B.G.2
Jin, G.3
Rago, C.4
Kapoor-Vazirani, P.5
Powell, D.R.6
Chi, J.T.7
Bigner, D.D.8
Vertino, P.M.9
Yan, H.10
-
9
-
-
78650019179
-
Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation
-
Figueroa ME, Abdel-Wahab O, Lu C, Ward PS, Patel J, Shih A, Li Y, Bhagwat N, Vasanthakumar A, Fernandez HF, Tallman MS, Sun Z, Wolniak K, Peeters JK, Liu W, Choe SE, et al. Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation. Cancer cell. 2010; 18(6):553-567.
-
(2010)
Cancer cell.
, vol.18
, Issue.6
, pp. 553-567
-
-
Figueroa, M.E.1
Abdel-Wahab, O.2
Lu, C.3
Ward, P.S.4
Patel, J.5
Shih, A.6
Li, Y.7
Bhagwat, N.8
Vasanthakumar, A.9
Fernandez, H.F.10
Tallman, M.S.11
Sun, Z.12
Wolniak, K.13
Peeters, J.K.14
Liu, W.15
Choe, S.E.16
-
10
-
-
84877632013
-
An inhibitor of mutant IDH1 delays growth and promotes differentiation of glioma cells
-
Rohle D, Popovici-Muller J, Palaskas N, Turcan S, Grommes C, Campos C, Tsoi J, Clark O, Oldrini B, Komisopoulou E, Kunii K, Pedraza A, Schalm S, Silverman L, Miller A, Wang F, et al. An inhibitor of mutant IDH1 delays growth and promotes differentiation of glioma cells. Science. 2013; 340(6132):626-630.
-
(2013)
Science.
, vol.340
, Issue.6132
, pp. 626-630
-
-
Rohle, D.1
Popovici-Muller, J.2
Palaskas, N.3
Turcan, S.4
Grommes, C.5
Campos, C.6
Tsoi, J.7
Clark, O.8
Oldrini, B.9
Komisopoulou, E.10
Kunii, K.11
Pedraza, A.12
Schalm, S.13
Silverman, L.14
Miller, A.15
Wang, F.16
-
11
-
-
0018860957
-
Cellular differentiation, cytidine analogs and DNA methylation
-
Jones PA and Taylor SM. Cellular differentiation, cytidine analogs and DNA methylation. Cell. 1980; 20(1):85-93.
-
(1980)
Cell.
, vol.20
, Issue.1
, pp. 85-93
-
-
Jones, P.A.1
Taylor, S.M.2
-
12
-
-
0021160287
-
5-Aza-2'-deoxycytidine induces terminal differentiation of leukemic blasts from patients with acute myeloid leukemias
-
Pinto A, Attadia V, Fusco A, Ferrara F, Spada OA and Di Fiore PP. 5-Aza-2'-deoxycytidine induces terminal differentiation of leukemic blasts from patients with acute myeloid leukemias. Blood. 1984; 64(4):922-929.
-
(1984)
Blood.
, vol.64
, Issue.4
, pp. 922-929
-
-
Pinto, A.1
Attadia, V.2
Fusco, A.3
Ferrara, F.4
Spada, O.A.5
Di Fiore, P.P.6
-
13
-
-
0020679784
-
Plasma and cerebrospinal fluid pharmacokinetics of 5-Aza-2'-deoxycytidine in rabbits and dogs
-
Chabot GG, Rivard GE and Momparler RL. Plasma and cerebrospinal fluid pharmacokinetics of 5-Aza-2'-deoxycytidine in rabbits and dogs. Cancer research. 1983; 43(2):592-597.
-
(1983)
Cancer research.
, vol.43
, Issue.2
, pp. 592-597
-
-
Chabot, G.G.1
Rivard, G.E.2
Momparler, R.L.3
-
14
-
-
84863337757
-
Transient low doses of DNA-demethylating agents exert durable antitumor effects on hematological and epithelial tumor cells
-
Tsai HC, Li H, Van Neste L, Cai Y, Robert C, Rassool FV, Shin JJ, Harbom KM, Beaty R, Pappou E, Harris J, Yen RW, Ahuja N, Brock MV, Stearns V, Feller-Kopman D, et al. Transient low doses of DNA-demethylating agents exert durable antitumor effects on hematological and epithelial tumor cells. Cancer cell. 2012; 21(3):430-446.
-
(2012)
Cancer cell.
, vol.21
, Issue.3
, pp. 430-446
-
-
Tsai, H.C.1
Li, H.2
Van Neste, L.3
Cai, Y.4
Robert, C.5
Rassool, F.V.6
Shin, J.J.7
Harbom, K.M.8
Beaty, R.9
Pappou, E.10
Harris, J.11
Yen, R.W.12
Ahuja, N.13
Brock, M.V.14
Stearns, V.15
Feller-Kopman, D.16
-
15
-
-
33746557450
-
Mass spectrometrical analysis of galectin proteins in primary rat cerebellar astrocytes
-
Yang JW, Kang SU, Engidawork E, Rodrigo R, Felipo V and Lubec G. Mass spectrometrical analysis of galectin proteins in primary rat cerebellar astrocytes. Neurochemical research. 2006; 31(7):945-955.
-
(2006)
Neurochemical research.
, vol.31
, Issue.7
, pp. 945-955
-
-
Yang, J.W.1
Kang, S.U.2
Engidawork, E.3
Rodrigo, R.4
Felipo, V.5
Lubec, G.6
-
16
-
-
39849096853
-
The transcriptional repressor NIPP1 is an essential player in EZH2-mediated gene silencing
-
Nuytten M, Beke L, Van Eynde A, Ceulemans H, Beullens M, Van Hummelen P, Fuks F and Bollen M. The transcriptional repressor NIPP1 is an essential player in EZH2-mediated gene silencing. Oncogene. 2008; 27(10):1449-1460.
-
(2008)
Oncogene.
, vol.27
, Issue.10
, pp. 1449-1460
-
-
Nuytten, M.1
Beke, L.2
Van Eynde, A.3
Ceulemans, H.4
Beullens, M.5
Van Hummelen, P.6
Fuks, F.7
Bollen, M.8
-
17
-
-
84655163371
-
Combination epigenetic therapy has efficacy in patients with refractory advanced non-small cell lung cancer
-
Juergens RA, Wrangle J, Vendetti FP, Murphy SC, Zhao M, Coleman B, Sebree R, Rodgers K, Hooker CM, Franco N, Lee B, Tsai S, Delgado IE, Rudek MA, Belinsky SA, Herman JG, et al. Combination epigenetic therapy has efficacy in patients with refractory advanced non-small cell lung cancer. Cancer discovery. 2011; 1(7):598-607.
-
(2011)
Cancer discovery.
, vol.1
, Issue.7
, pp. 598-607
-
-
Juergens, R.A.1
Wrangle, J.2
Vendetti, F.P.3
Murphy, S.C.4
Zhao, M.5
Coleman, B.6
Sebree, R.7
Rodgers, K.8
Hooker, C.M.9
Franco, N.10
Lee, B.11
Tsai, S.12
Delgado, I.E.13
Rudek, M.A.14
Belinsky, S.A.15
Herman, J.G.16
-
18
-
-
84860528199
-
Epigenetic resensitization to platinum in ovarian cancer
-
Matei D, Fang F, Shen C, Schilder J, Arnold A, Zeng Y, Berry WA, Huang T and Nephew KP. Epigenetic resensitization to platinum in ovarian cancer. Cancer research. 2012; 72(9):2197-2205.
-
(2012)
Cancer research.
, vol.72
, Issue.9
, pp. 2197-2205
-
-
Matei, D.1
Fang, F.2
Shen, C.3
Schilder, J.4
Arnold, A.5
Zeng, Y.6
Berry, W.A.7
Huang, T.8
Nephew, K.P.9
-
19
-
-
84886741979
-
5-azacytidine reduces methylation, promotes differentiation and induces tumor regression in a patient-derived IDH1 mutant glioma xenograft
-
Borodovsky A, Salmasi V, Turcan S, Baia G, Eberhart C, Weingart J, Gallia G, Baylin S, Chan T and Riggins G. 5-azacytidine reduces methylation, promotes differentiation and induces tumor regression in a patient-derived IDH1 mutant glioma xenograft. Oncotarget. 2013.
-
(2013)
Oncotarget.
-
-
Borodovsky, A.1
Salmasi, V.2
Turcan, S.3
Baia, G.4
Eberhart, C.5
Weingart, J.6
Gallia, G.7
Baylin, S.8
Chan, T.9
Riggins, G.10
-
20
-
-
61449172037
-
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
-
Huang da W, Sherman BT and Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nature protocols. 2009; 4(1):44-57.
-
(2009)
Nature protocols.
, vol.4
, Issue.1
, pp. 44-57
-
-
Da Huang, W.1
Sherman, B.T.2
Lempicki, R.A.3
|